222 related articles for article (PubMed ID: 9879742)
1. Angiotensin-(1-7): a bioactive fragment of the renin-angiotensin system.
Ferrario CM; Iyer SN
Regul Pept; 1998 Nov; 78(1-3):13-8. PubMed ID: 9879742
[TBL] [Abstract][Full Text] [Related]
2. Antihypertensive effects of angiotensin-(1-7).
Chappell MC; Iyer SN; Diz DI; Ferrario CM
Braz J Med Biol Res; 1998 Sep; 31(9):1205-12. PubMed ID: 9876288
[TBL] [Abstract][Full Text] [Related]
3. Release of angiotensin-(1-7) from the rat hindlimb: influence of angiotensin-converting enzyme inhibition.
Chappell MC; Gomez MN; Pirro NT; Ferrario CM
Hypertension; 2000 Jan; 35(1 Pt 2):348-52. PubMed ID: 10642323
[TBL] [Abstract][Full Text] [Related]
4. Angiotension-(1-7) and antihypertensive mechanisms.
Ferrario CM
J Nephrol; 1998; 11(6):278-83. PubMed ID: 10048492
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system.
Iyer SN; Ferrario CM; Chappell MC
Hypertension; 1998 Jan; 31(1 Pt 2):356-61. PubMed ID: 9453328
[TBL] [Abstract][Full Text] [Related]
6. Evidence that prostaglandins mediate the antihypertensive actions of angiotensin-(1-7) during chronic blockade of the renin-angiotensin system.
Iyer SN; Yamada K; Diz DI; Ferrario CM; Chappell MC
J Cardiovasc Pharmacol; 2000 Jul; 36(1):109-17. PubMed ID: 10892668
[TBL] [Abstract][Full Text] [Related]
7. Novel angiotensin peptides regulate blood pressure, endothelial function, and natriuresis.
Ferrario CM; Chappell MC; Dean RH; Iyer SN
J Am Soc Nephrol; 1998 Sep; 9(9):1716-22. PubMed ID: 9727381
[TBL] [Abstract][Full Text] [Related]
8. Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.
Husková Z; Kopkan L; Červenková L; Doleželová Š; Vaňourková Z; Škaroupková P; Nishiyama A; Kompanowska-Jezierska E; Sadowski J; Kramer HJ; Červenka L
Clin Exp Pharmacol Physiol; 2016 Apr; 43(4):438-49. PubMed ID: 26833491
[TBL] [Abstract][Full Text] [Related]
9. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.
Ferrario CM; Jessup J; Gallagher PE; Averill DB; Brosnihan KB; Ann Tallant E; Smith RD; Chappell MC
Kidney Int; 2005 Nov; 68(5):2189-96. PubMed ID: 16221218
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II-independent angiotensin-(1-7) formation in rat hippocampus: involvement of thimet oligopeptidase.
Pereira MG; Souza LL; Becari C; Duarte DA; Camacho FR; Oliveira JA; Gomes MD; Oliveira EB; Salgado MC; Garcia-Cairasco N; Costa-Neto CM
Hypertension; 2013 Nov; 62(5):879-85. PubMed ID: 24041943
[TBL] [Abstract][Full Text] [Related]
11. Primacy of cardiac chymase over angiotensin converting enzyme as an angiotensin-(1-12) metabolizing enzyme.
Ahmad S; Varagic J; VonCannon JL; Groban L; Collawn JF; Dell'Italia LJ; Ferrario CM
Biochem Biophys Res Commun; 2016 Sep; 478(2):559-64. PubMed ID: 27465904
[TBL] [Abstract][Full Text] [Related]
12. Mapping tissue angiotensin-converting enzyme and angiotensin AT1, AT2 and AT4 receptors.
Zhuo J; Moeller I; Jenkins T; Chai SY; Allen AM; Ohishi M; Mendelsohn FA
J Hypertens; 1998 Dec; 16(12 Pt 2):2027-37. PubMed ID: 9886893
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-(1-7) potentiates the hypotensive effect of bradykinin in conscious rats.
Paula RD; Lima CV; Khosla MC; Santos RA
Hypertension; 1995 Dec; 26(6 Pt 2):1154-9. PubMed ID: 7498987
[TBL] [Abstract][Full Text] [Related]
14. [Active metabolites derived from angiotensin II].
Chansel D; Ardaillou R
Nephrologie; 1998; 19(7):427-32. PubMed ID: 9857379
[TBL] [Abstract][Full Text] [Related]
15. The renin-angiotensin system and its vasoactive metabolite angiotensin-(1-7) in the mechanism of the healing of preexisting gastric ulcers. The involvement of Mas receptors, nitric oxide, prostaglandins and proinflammatory cytokines.
Pawlik MW; Kwiecien S; Ptak-Belowska A; Pajdo R; Olszanecki R; Suski M; Madej J; Targosz A; Konturek SJ; Korbut R; Brzozowski T
J Physiol Pharmacol; 2016 Feb; 67(1):75-91. PubMed ID: 27010897
[TBL] [Abstract][Full Text] [Related]
16. Counter-regulatory effects played by the ACE - Ang II - AT1 and ACE2 - Ang-(1-7) - Mas axes on the reactive oxygen species-mediated control of vascular function: perspectives to pharmacological approaches in controlling vascular complications.
Pernomian L; Pernomian L; Baraldi Araújo Restini C
Vasa; 2014 Nov; 43(6):404-14. PubMed ID: 25339158
[TBL] [Abstract][Full Text] [Related]
17. Effects of losartan on angiotensin and bradykinin peptides and angiotensin-converting enzyme.
Campbell DJ; Kladis A; Valentijn AJ
J Cardiovasc Pharmacol; 1995 Aug; 26(2):233-40. PubMed ID: 7475048
[TBL] [Abstract][Full Text] [Related]
18. Characterization of renin-angiotensin system enzyme activities in cultured mouse podocytes.
Velez JC; Bland AM; Arthur JM; Raymond JR; Janech MG
Am J Physiol Renal Physiol; 2007 Jul; 293(1):F398-407. PubMed ID: 17429035
[TBL] [Abstract][Full Text] [Related]
19. Biosynthesis and physio-pharmacological actions of angiotensin peptides: 1. Synthetic enzymes.
Haulică I; Bild W; Rădăşanu O
Rev Med Chir Soc Med Nat Iasi; 2006; 110(1):167-72. PubMed ID: 19292099
[TBL] [Abstract][Full Text] [Related]
20. Critical Role of Neprilysin in Kidney Angiotensin Metabolism.
Kaltenecker CC; Domenig O; Kopecky C; Antlanger M; Poglitsch M; Berlakovich G; Kain R; Stegbauer J; Rahman M; Hellinger R; Gruber C; Grobe N; Fajkovic H; Eskandary F; Böhmig GA; Säemann MD; Kovarik JJ
Circ Res; 2020 Aug; 127(5):593-606. PubMed ID: 32418507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
